Categorized | Melanoma News, MRV Research

Australian Stage 3 melanoma patients forced to self-fund recurrent treatment while PBS makes decision on listing

Source: , June 2018

AN AUSTRALIAN man has said the decision to pay $100,000 to self-fund his own treatment was more stressful than being told he had cancer.

The news comes as patients struggle to afford prevention treatment while regulators battle to keep up with the latest in breakthrough cancer research.

read the original full article